Cleveland Heartlab Obtains $3,000,000 New Financing Round

  • Feed Type
  • Date
    3/2/2010
  • Company Name
    Cleveland Heartlab
  • Mailing Address
    10265 Carnegie Avenue Cleveland, OH 44106
  • Company Description
    Cleveland HeartLab, LLC is a specialty clinical laboratory and disease management company focused on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. Cleveland HeartLab (CHL) operates a CAP-accredited and CLIA-certified Clinical Laboratory located on the main campus of the Cleveland Clinic and receives samples from doctors’ offices and hospitals all across the country. CHL has developed a profile of tests focused on managing and reducing inflammation, a root cause of heart disease. In addition to our Inflammatory Profile we have an array of tests that doctors can choose from.
  • Website
    http://www.clevelandheartlab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds will be used to do three things, primarily. First, expand our sales and marketing efforts, and our reach out of the region. Second, to build up our operations internally. And third is to continue to advance valuable Cleveland Clinic technology and get it into the market.
  • M&A Terms
  • Venture Investor
    Glengary
  • Venture Investor
    Zapis Capital Group
  • Venture Investor
    Second Generation
  • Venture Investor
    Undisclosed